Patent AT-E401392-T1: [Translated] SUBTYPE-MATCHED INACTIVATED WHOLE VIRUS VACCINE FOR THE TREATMENT OF PATIENTS WITH HIV INFECTION

Description

Inactivated whole HIV of a particular subtype is used for vaccines and pharmaceutical compositions containing the vaccines. The vaccines can be used to treat individuals chronically infected with HIV, by inducing a protective cellular immune response in the individuals against the same HIV subtype used to produce the vaccine.

Resources

Name Format Description Link
21 Access the complete Patent AT-E401392-T1: [Translated] SUBTYPE-MATCHED INACTIVATED WHOLE VIRUS VACCINE FOR THE TREATMENT OF PATIENTS WITH HIV INFECTION on the official website. https://pubchem.ncbi.nlm.nih.gov/patent/AT-E401392-T1

Tags

  • patent
  • chemistry
  • research
  • innovation
  • pubchem

Topics

Categories